Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Jyong Biotech Ltd. (MENS)

Compass Therapeutics, Inc. and Jyong Biotech Ltd. are both Biotechnology companies. Compass Therapeutics, Inc. and Jyong Biotech Ltd. are of similar size ($136.7M and $133.6M). Across the 4 metrics below, Compass Therapeutics, Inc. leads on 2 and Jyong Biotech Ltd. on 2.

Valuation

Metric CMPX MENS Biotechnology median
P/E n/m — 10.60
P/S n/m — 9.40
P/B 0.86 n/m 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA 0.40 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (52.63%) — (32.88%)
Free cash flow yield (39.71%) — (23.13%)

Profitability

Metric CMPX MENS Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (56.66%) — (51.96%)
Return on assets (47.87%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX MENS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (16.67%) (42.18%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CMPX MENS Biotechnology median
Debt to equity 0.00 (0.74) 0.00
Current ratio 11.22 0.45 4.97
Net debt to EBITDA 2.86 (6.89) 1.01

Dividend

Metric CMPX MENS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMPX MENS Biotechnology median
Market cap 136.65m 133.62m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack